Patients For Affordable Drugs Announces New Communications Director
As The Fight To Lower Drug Prices Ramps Up, Audrey Baker Will Lead P4AD’s Communications Efforts
Without this medicine, I would be unable to move.
A system that allows runaway drug prices like these places a burden not only on patients themselves, but on everyone in this country by way of the outsized financial responsibility paid by taxpayers.
I don’t know how I will afford my medicine.
My symptoms shouldn’t worsen just because a drug company wants to make a few extra dollars of profit off of my diagnosis.
I had to ration my insulin for almost a year.
By the time I was about to turn 19, I was almost out of insulin and I ended up in diabetic ketoacidosis –– a serious condition that can lead to death.
I feel like I’m working my job just to afford my medicine.
Between the high cost of insulin and other supplies, affording the necessary treatments to survive as a diabetic can be incredibly costly.
Big Pharma’s Big Lie: The Truth About Innovation and Drug Pricing
New Report Debunks Pharma's Claim That Any Restraint On Its Unilateral Pricing Power Will Destroy Innovation And Access To New Medicines.
Big Pharma’s Big Lie: The Truth About Innovation & Drug Prices
Can we constrain drug corporations’ unfettered pricing power in the United States and still get the innovation we seek?
Drug Company Price Hikes: Look Again
35 pharmaceutical corporations waited until scrutiny on the initial 2021 price hikes faded before hiking prices.
